These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29072615)

  • 1. The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
    Ji L; Liu X; Zhang S; Tang S; Yang S; Li S; Qi X; Yu S; Lu L; Meng X; Liu Z
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
    Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
    Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
    Ma X; Zhou X; Qu H; Ma Y; Yue Z; Shang W; Wang P; Xie S; Li Y; Sun Y
    Oncol Rep; 2018 Apr; 39(4):1910-1918. PubMed ID: 29436678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
    Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation.
    Fang Z; Chen W; Yuan Z; Liu X; Jiang H
    Biomed Pharmacother; 2018 May; 101():536-542. PubMed ID: 29505924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
    Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells.
    Seo HS; Ku JM; Lee HJ; Woo JK; Cheon C; Kim M; Jang BH; Shin YC; Ko SG
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28864784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by icaritin in doxorubicin-resistant human osteosarcoma cells.
    Wang ZD; Wang RZ; Xia YZ; Kong LY; Yang L
    Chin J Nat Med; 2018 Jan; 16(1):20-28. PubMed ID: 29425587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
    Robey RW; Zhan Z; Piekarz RL; Kayastha GL; Fojo T; Bates SE
    Clin Cancer Res; 2006 Mar; 12(5):1547-55. PubMed ID: 16533780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinnamaldehyde derivative (CB-PIC) sensitizes chemo-resistant cancer cells to drug-induced apoptosis via suppression of MDR1 and its upstream STAT3 and AKT signalling.
    Yun M; Lee D; Park MN; Kim EO; Sohn EJ; Kwon BM; Kim SH
    Cell Physiol Biochem; 2015; 35(5):1821-30. PubMed ID: 25833196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
    Yakisich JS; Venkatadri R; Azad N; Iyer AKV
    J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.